MR imaging of renal function.

Magn Reson Imaging Clin N Am

Mallinckrodt Institute of Radiology, Washington University Medical Center, St. Louis, Missouri.

Published: February 1997

MR imaging has advantages over both computed tomography and nuclear scintigraphy for assessing renal function, because it combines high spatial resolution with information on perfusion and function. A further advantage is the lack of ionizing radiation. Quantitation of flow rate by phase contrast in the renal arteries and veins has the potential to provide estimation of renal blood flow, which could prove useful in a number of clinical situations, especially for studying renal vascular disorders and the effects of treatment, and for assessing renal transplants. Evaluation of renal perfusion with MR imaging has become feasible with the development of rapid data acquisition techniques, which provide adequate temporal resolution to monitor the rapid signal changes during the first passage of the contrast agents in the kidneys. More recently, magnetically labeling water protons in blood flowing into kidneys has been used to noninvasively quantitate regional measurement of cortical and medullary perfusion. Other techniques being investigated with MR imaging for assessment of renal function include diffusion imaging GFR estimation and blood oxygenation level dependent imaging to evaluate intrarenal oxygenation levels.

Download full-text PDF

Source

Publication Analysis

Top Keywords

renal function
12
assessing renal
8
renal
7
imaging
6
imaging renal
4
function
4
function imaging
4
imaging advantages
4
advantages computed
4
computed tomography
4

Similar Publications

Effects of stress hyperglycemia ratio upon long-lasting prognosis in coronary artery disease patients with or lacking chronic renal impairment: findings from a Chinese multi-center observational study.

Diabetol Metab Syndr

December 2024

Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, 510080, China.

Background: Lately, numerous researches have portrayed stress hyperglycemia ratio (SHR) is predominantly connected with short-term adverse prognosis among individuals who have acute coronary syndrome. Nevertheless, the relation of SHR with prolonged effects and the value of SHR in predicting in coronary artery disease (CAD) patients with or lacking chronic kidney disease (CKD) remain unclear. The present study was designed to elucidate the relation of SHR with prolonged prognosis and the value of SHR in predicting the long-term all-cause and cardiovascular death of CAD patients with CKD or non-CKD.

View Article and Find Full Text PDF

Background/aim: Hydrogen therapy has demonstrated potential as an antioxidant and anti-inflammatory intervention, particularly in the management of chronic diseases such as chronic kidney disease (CKD) and autoimmune conditions. This case report presents the possible therapeutic benefits of molecular hydrogen capsule treatment in enhancing renal function and alleviating chronic fatigue in an elderly female with coronary artery disease (CAD), type 2 diabetes mellitus (DM) complicated by nephropathy, and systemic lupus erythematosus (SLE). The aim of this study was to investigate the efficacy of adjunctive hydrogen therapy in an elderly patient with multiple chronic comorbidities.

View Article and Find Full Text PDF

Background/aim: Clear cell renal cell carcinoma (ccRCC) represents the most common type of renal cancer. When resectable, nephrectomy is the only radical treatment for ccRCC, however metastasis is already present at 30% of the patient population. Although great progress has been made in the field of targeted therapy with the emergence of immune checkpoint inhibitors (ICIs) the cure of metastatic ccRCC (mccRCC) remains far from achieved.

View Article and Find Full Text PDF

Background/aim: Immuno-oncology (IO) improves the prognosis of advanced renal cell carcinoma (RCC). Since research has so far been limited to clinical trials, we herein focused on the effects of IO-tyrosine kinase inhibitor (TKI) combination therapy in real-world clinical settings.

Patients And Methods: We conducted a retrospective study on 125 patients with advanced RCC who received IO-TKI combination therapy or TKI monotherapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!